Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujuan Yuan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2011
CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumorSujuan Yuan, Tiankui Qiao, Wei Chen
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 24, 2011
[Correlation between chlamydia pneumoniae IgG positive in lung cancer patients and cytokines related to radiation-induced pulmonary lesion]Wenyi Zhang, Tiankui Qiao, Daoan Zhou, et al.
Cancer Management and Research|June 11, 2021
The Preliminary Study for Postoperative Radiotherapy Survival Associated with <i>RUNX3</i> and <i>TLR9</i> Expression in Lung CancerCaixia Gao, Tiankui Qiao, Sujuan Yuan, et al.
Oncology Letters|March 21, 2018
HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-κB signaling pathwayWei Chen, Xiaoqun Liu, Sujuan Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cellsLin Zha, Tiankui Qiao, Sujuan Yuan, et al.
Oncotargets and Therapy|December 13, 2012
Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cellsWei Chen, Xiaoqun Liu, Tiankui Qiao, et al.
BMC Biotechnology|January 22, 2014
Ubiquitin-like prokaryotic MoaD as a fusion tag for expression of heterologous proteins in Escherichia coliSujuan Yuan, Xin Wang, Jian Xu, et al.
Oxidative Medicine and Cellular Longevity|July 18, 2022
Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung InjuryXuan Li, Jingyao Chen, Sujuan Yuan, et al.
Oncotargets and Therapy|July 23, 2016
Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trialsXiaoqun Liu, Xiangdong Liu, Tiankui Qiao, et al.
Oncotargets and Therapy|June 20, 2015
The effect of ataxia-telangiectasia mutated kinase-dependent hyperphosphorylation of checkpoint kinase-2 on oligodeoxynucleotide 7909 containing CpG motifs-enhanced sensitivity to X-rays in human lung adenocarcinoma A549 cellsXiaoqun Liu, Xiangdong Liu, Tiankui Qiao, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2011
CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumorSujuan Yuan, Tiankui Qiao, Wei Chen
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|February 24, 2011
[Correlation between chlamydia pneumoniae IgG positive in lung cancer patients and cytokines related to radiation-induced pulmonary lesion]Wenyi Zhang, Tiankui Qiao, Daoan Zhou, et al.
Cancer Management and Research|June 11, 2021
The Preliminary Study for Postoperative Radiotherapy Survival Associated with <i>RUNX3</i> and <i>TLR9</i> Expression in Lung CancerCaixia Gao, Tiankui Qiao, Sujuan Yuan, et al.
Oncology Letters|March 21, 2018
HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-κB signaling pathwayWei Chen, Xiaoqun Liu, Sujuan Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cellsLin Zha, Tiankui Qiao, Sujuan Yuan, et al.
Oncotargets and Therapy|December 13, 2012
Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cellsWei Chen, Xiaoqun Liu, Tiankui Qiao, et al.
BMC Biotechnology|January 22, 2014
Ubiquitin-like prokaryotic MoaD as a fusion tag for expression of heterologous proteins in Escherichia coliSujuan Yuan, Xin Wang, Jian Xu, et al.
Oxidative Medicine and Cellular Longevity|July 18, 2022
Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung InjuryXuan Li, Jingyao Chen, Sujuan Yuan, et al.
Oncotargets and Therapy|July 23, 2016
Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trialsXiaoqun Liu, Xiangdong Liu, Tiankui Qiao, et al.
Oncotargets and Therapy|June 20, 2015
The effect of ataxia-telangiectasia mutated kinase-dependent hyperphosphorylation of checkpoint kinase-2 on oligodeoxynucleotide 7909 containing CpG motifs-enhanced sensitivity to X-rays in human lung adenocarcinoma A549 cellsXiaoqun Liu, Xiangdong Liu, Tiankui Qiao, et al.
Pageof 3